EZ Cap™ Cas9 mRNA (m1Ψ): Assay Design
2026-08-11
EZ Cap™ Cas9 mRNA (m1Ψ) supports CRISPR-Cas9 genome editing through a Cap1-capped, m1Ψ-modified RNA format. This article explains how transient Cas9 expression, RNA handling, and nuclear-export biology should shape precision-editing assay design.
Ibrutinib (PCI-32765): A BTK Research Strategy
2026-08-10
Ibrutinib (PCI-32765) offers a mechanistically defined way to interrogate BTK-dependent B-cell biology. This translational framework connects B-cell receptor signaling inhibition, chronic lymphocytic leukemia research, autoimmune disease models, and carefully bounded lessons from ATRX-deficient glioma studies.
Syringin: An Assay-First Guide to RCC Research
2026-08-09
Explore Syringin natural product research through an assay-first framework for renal cell carcinoma models. This guide connects chemical quality, EGFR/PI3K/Akt pathway interpretation, combination testing, and practical controls.
TBST and the Translational Logic of uPAR Inhibition
2026-08-08
Mechanistic cancer biology depends on measurement quality. This thought-leadership article connects ensemble-based uPAR·uPA inhibitor discovery with disciplined TBST use, showing how buffer control can strengthen immunoassay interpretation without confusing analytical rigor with therapeutic efficacy.
GW 4869: Exosome Workflow and Osteogenesis
2026-08-07
GW 4869 is a practical pharmacological probe for separating exosome-dependent signaling from direct effects on donor or recipient cells. This workflow shows how to use GW 4869 hydrochloride hydrate to interrogate lithium-engineered BMSC exosomes, ceramide-linked signaling, and extracellular vesicle release while controlling solvent, dose, and assay artifacts.
AT-406 (SM-406): Applied Workflows for Cancer Apoptosis Rese
2026-08-07
AT-406 (SM-406) empowers cancer researchers with robust, reproducible induction of apoptosis by antagonizing multiple IAPs. This guide translates bench-proven protocols, advanced workflow enhancements, and troubleshooting insights into actionable steps for maximizing experimental success in oncology models.
U 46619: A Translational Bridge in Platelet and Vascular Res
2026-08-06
This article explores U 46619’s mechanistic precision as a TP receptor agonist, its centrality in modeling platelet and vascular dynamics, and its emerging relevance in renal ischemia-reperfusion injury research. With actionable protocol guidance and a critical perspective on translational impact, it offers researchers a competitive edge in experimental design and outcome interpretation.
Lyotropic Phase Behavior of Coil-Bottlebrush Diblocks in Ion
2026-08-06
Rodriguez et al. advance the understanding of lyotropic self-assembly in coil-bottlebrush diblock copolymers by revealing that their phase behavior in alkylimidazolium-based ionic liquids is remarkably independent of ionic liquid alkyl chain length. This insight broadens the design space for network nanostructures, overcoming previous compositional limitations and guiding the development of functional nanomaterials.
Acetylcysteine in Oxidative Stress Pathway Modulation: Proto
2026-08-05
Acetylcysteine (N-acetyl-L-cysteine) enables precision redox modulation and mucolytic intervention across diverse experimental systems. This guide translates the latest bench findings into practical workflows, troubleshooting advice, and strategic tips for leveraging Acetylcysteine in oxidative stress, hepatic, and neurodegenerative research.
Cyclopamine in Translational Oncology: Mechanisms, Strategy,
2026-08-05
This thought-leadership article explores Cyclopamine’s mechanistic role as a Hedgehog signaling inhibitor, with a focus on its translational value in cancer research and recent evidence of synergy with APOC1 targeting in thyroid carcinoma. It provides strategic guidance for researchers, protocol insights, and a forward-looking outlook on integrating pathway inhibition with emerging molecular targets.
Dextran Sulfate Sodium Salt (MW 35000-45000): Beyond Inducti
2026-08-04
Explore how Dextran sulfate sodium salt (MW 35000-45000) not only induces colitis in mouse models but also advances our mechanistic understanding of mucosal repair and epithelial signaling in IBD research. This in-depth guide provides actionable insights for optimizing experimental design using DSS.
CHI3L1-IN-5 (Compound Z17): Redefining Astrocyte Function in
2026-08-04
Explore how CHI3L1-IN-5 (Compound Z17) sets a new standard as a CHI3L1 inhibitor for Alzheimer’s research. This article delivers a unique perspective on astrocyte-mediated amyloid clearance, integrating original mechanistic insights and practical protocol guidance.
AI-10-49 CBFβ-SMMHC Inhibitor: Applied Workflows in AML
2026-08-03
AI-10-49 offers acute myeloid leukemia researchers a precise, potent tool to interrogate and disrupt the CBFβ-SMMHC oncoprotein axis. This guide translates the latest mechanistic findings into actionable workflows, protocol optimizations, and troubleshooting strategies for advanced AML research.
Isoliensinine Attenuates Neuroinflammation via MAPK/NF-κB Mo
2026-08-03
This study demonstrates that isoliensinine, a bisbenzylisoquinoline alkaloid, confers neuroprotection and reduces LPS-induced neuroinflammation in microglial cells by modulating the MAPK/NF-κB pathway. The findings highlight a promising avenue for targeting neuroinflammation and oxidative stress in Alzheimer’s disease models.
Alfuzosin HCl in Advanced α1 Adrenoceptor Antagonist Workflo
2026-08-02
Leverage Alfuzosin HCl as a selective α1 adrenoceptor antagonist for translational benign prostatic hyperplasia research, optimized for reproducibility and high bioavailability. This guide covers innovative gastroretentive delivery, troubleshooting, and actionable protocol parameters to empower applied urinary tract research.
460 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page